Objective The sterilization of medical devices (such as implants, artificial joints, syringes, blood bags), as well as ‘tetrapacks’, food packaging, and even wine corks, is currently performed by third-parties. This adds time and costs to the final and critical part of the manufacturing process. Many new medical devices cannot be sterilized through radiation and can only be sterilized through chemical gas processes that results in harmful gases remaining in the packaging which can be harmful to end users of the products such as hospital staff. Moreover, medical device sterilization is currently not properly documented and controlled, often causing broad product recalls should a single product be found to be non-sterile. This adds further expense and delay due to the need to repeat the sterilization process. EnXray has developed an innovative sterilization machine that delivers high efficiency ionizing radiation, using low energy Xray’s to reach the Sterility Assurance Level, in an affordable manner enabling safe on-site and on-demand sterilization of medical devices. It can be installed on site at each production facility helping manufacturing companies to reduce production costs and times. Furthermore, the current inventory holding costs incurred by medical device manufacturing companies could be reduced substantially by EnXray’s technology thanks to the reliable sterilisation process. Within the overall project EnXray intend to optimise the commercial design according to medical partner requirements, demonstrate it for use in converyor processing, develop a better understanding of its impact on new plastic materials as well as fully establish the commercialisation strategy. Fields of science engineering and technologymechanical engineeringmanufacturing engineeringnatural sciencesphysical sciencesnuclear physicsnatural sciencesearth and related environmental sciencesenvironmental sciencespollutionengineering and technologyother engineering and technologiesfood technologyfood packagingmedical and health sciencesmedical biotechnologyimplants Programme(s) H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies Main Programme H2020-EU.2.1.5. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Topic(s) SMEInst-02-2016-2017 - Accelerating the uptake of nanotechnologies advanced materials or advanced manufacturing and processing technologies by SMEs Call for proposal H2020-SMEInst-2016-2017 See other projects for this call Sub call H2020-SMEINST-1-2016-2017 Funding Scheme SME-1 - SME instrument phase 1 Coordinator ENXRAY LIMITED Net EU contribution € 50 000,00 Address Liverpool innovation park edge lane L7 9NJ Liverpool United Kingdom See on map Region North West (England) Merseyside Liverpool Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 21 429,00
